☰ Accessibility
September 19, 2025

Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, announced that its biosimilar Yesafili (aflibercept) has been included under Ontario’s public insurance system in Canada, improving access for patients with serious retinal disorders. Broader Access Through Public Coverage The funding applies to both vial and prefilled syringe presentations…

Market-View-Feature-Image
September 19, 2025

View on market: Volatility persists, eagerly searching for growth: Asian shares moved mixed after strong cues from the United States and other global markets following the latest interest-rate cut by the US Federal Reserve. Japanese stocks opened firmly higher, while South Korean shares moved slightly lower. Australian shares…